Autosomal dominant optic atrophy (ADOA), the most common genetic optic neuropathy, is an insidious disease. It often presents ...

The newly published results of two small clinical trials suggest that two novel antibiotics could provide safer alternatives ...

Common causes of this type of vision field loss include toxic or nutritional optic neuropathy and hereditary optic neuropathy. Since dominant optic atrophy causes chronic progressive visual loss over ...

Prolonged vitamin B12 deficiency is known to cause peripheral paresthesia, gait abnormalities and toxic optic neuropathy, but the progressive nature of our patient’s presentation along with his ...

Toxic optic neuropathy. Alcohol contains toxins that can directly damage the optic nerve. Over time, this damage can accumulate, leading to a condition known as toxic optic neuropathy, which can ...

Autosomal dominant optic atrophy (ADOA), the most common genetic optic neuropathy, is an insidious disease. It often presents slowly during childhood by way of blurry vision, trouble reading or ...

An optic nerve that has an injury cannot be fixed, so usually, if there is vision loss from ischemic optic neuropathy, it is permanent. Those with badly damaged optic nerves usually can still see ...

Berna Gomez's world was turned upside down when she was diagnosed with toxic optic neuropathy at age 42. The rapidly progressing disease deteriorated the Spanish science teacher's optic nerves and ...

They considered his visual symptoms to be "highly suggestive of a toxic optic neuropathy with acute, painless, bilateral onset of anterior optic pathway pathology, dyschromatopsia, ...

Recent research introduces a soft, injectable material designed for use in the eye to help protect and support damaged ...

Traumatic optic nerve head avulsion and traumatic optic neuropathy are serious and can be visually devastating. Most cases have poor prognosis for visual recovery, leaving patients with minimal or ...

A recent meta-analysis of 69 clinical trials found the risk for ischemic optic neuropathy from GLP-1 therapy is too low to be detected in patients with type 2 diabetes and/or obesity.